Sarah Cuddy BWH Amyloidosis Program Dr. Michael Salerno M.D. P.h.D Brigham and Women’s Cardiovascular Imaging Program Society for Cardiovascular Magnetic Resonance Fantastic talk with so much information even for non MRI experts! Dr. Michael Salerno M.D. P.h.D educated us on standardization of metrics and factors impacting native T1 and ECV. Need high resolution imaging for RV ECV

10th Annual Brigham and Women’s Cardiovascular Imaging Program Cardiovascular Imaging Research Conference led by Dr Marcelo Di Carli with visiting professor Dr Susan Cheng from Cedars-Sinai

What an amazing group of people that I have had the privilege to train with over the past 2 years! Brigham and Women’s Cardiovascular Imaging Program 10th annual research day led by Dr. Marcelo Di Carli! We loved having Dr. Susan Cheng from Cedars-Sinai & are so grateful for the time she took out to meet & mentor fellows!

Check out this exciting new investigation into the performance of AT-01 (124I-evuzamitide) PET/CT and a comparison to 18F florbetapir by Sharmila Dorbala Sarah Cuddy et al. jacc.org/doi/10.1016/j.… #CardioTwitter #CVNuc

ASNC Society 2023 rising star award goes to Sarah Cuddy! Sarah is also a rising star in #cardiacamyloidosis #CVimaging BWH Amyloidosis Program Brigham and Women’s Cardiovascular Imaging Program Rodney Falk MD Marcelo Di Carli #ASNC2023

Girl power 💪 - celebrating the inspirational and enlightening Women in Cardiology (WIN) at ASNC Society, including the amazing women at Brigham and Women’s Cardiovascular Imaging Program Harvard Medical School Sharmila Dorbala Sarah Cuddy Brittany Weber Raya Mannan Shilpa Vijayakumar Anam Waheed, MD Diana López, MD Esra Gucuk Ipek Monika Nukala, MD Thankyou!

Great #ASNC2023 dinner w/ Brigham and Women’s Cardiovascular Imaging Program program and friends. Thx Niti R. Aggarwal, MD, FSCMR, FASNC, FACC for the culinary tip re Queen of Sheba Toronto

Syncope Imaging the 411: Emerging Clinical and Imaging Insights #AHA23

124I-evuzamitide PET/CT accurately identifies cardiac light chain & TTR #amyloidosis, excludes amyloid in healthy controls, & may be better than 18F-florbetapir for TTR quantification. bit.ly/46bb7LN #ThinkPET #cvPET #JACCIMG Shilpa Vijayakumar Sharmila Dorbala

💙Masterclass in Cardiac #Amyloidosis ASNC Society Saurabh Malhotra Lawrence Phillips Day 1⃣⭐️ Prognostic markers in amyloidosis by Andrew Staron Andrew Staron BU Amyloidosis Center 👉ATTR

At today‘s ASNC Society webinar around the 🌎👉🏼 Dr. Elisa Milan presents an interesting case with dual pathology with cardiac amyloidosis and aortic stenosis: ✏️ TAVR should not be withheld! ✏️ Always exclude AL amyloidosis with serum & urine immunofixation and free light chains

This can change how we assess treatment response in #amyloidosis ‼️ ASNC Society Ahmad Masri Shilpa Vijayakumar Vasvi Singh

Fantastic talk by ASNC Society superstar Sarah Cuddy at #ICNCCT2024 on the emerging role of amyloid-binding PET radiotracers for diagnosis & assessment of treatment response in patients with cardiac amyloidosis. European Society of Cardiology Sharmila Dorbala Ahmad Masri Brett Sperry, MD Shilpa Vijayakumar

Huge congratulations to Dr. Olivier Clerc Olivier F. Clerc for being recognized as the ASNC Society rising star for his work on multimodality cardiovascular imaging with a focus on cardiac amyloidosis and cardiomyopathies! BWH Amyloidosis Program Sarah Cuddy Dominik C. Benz Rodney Falk MD Bianchi Lab

Congratulations to Marcelo Di Carli Legend and hero to all of us in ASNC Society Grateful for you generously sharing your time and wisdom #ASNC2025

S212. Best of Journal of Nuclear Cardiology 2024🌟 #ASNC2025 #CVNuc ❤️‍🔥By Dr. Shilpa Vijayakumar Brigham and Women's Hospital Sharmila Dorbala 👉 Quantitative PYP myocardial uptake: Changes on TTR stabilization therapy #Amyloidosis share.google/4pC7vQ1I6ESszF…

Tracking response to therapy in #Amyloidosis, with #CVNuc Dr. Shilpa Vijayakumar #ASNC2025 ASNC Society 2/2🔋 👉The decrease in CARI uptake seems to be indicative of the molecule stabilization rather that regression ♥️

In patients w/ ATTR-CM on TTR stabilizers, mortality did not differ among those w/ 99mTc-PYP visual grades 2 & 3, but higher NAC stage & worse NYHA class remained strong & independent predictors of mortality. #cvnuc Read now👉bit.ly/4haECEo